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Abstract: Screening of one-bead-one-compound (OBOC) libraries is a proven procedure for the
identification of protein-binding ligands. The demand for binders with high affinity and specificity
towards various targets has surged in the biomedical and pharmaceutical field in recent years.
The traditional peptide screening involves tedious steps such as affinity selection, bead picking,
sequencing, and characterization. Herein, we present a high-throughput “all-on-one chip” system to
avoid slow and technically complex bead picking steps. On a traditional glass slide provided with an
electrically conductive tape, beads of a combinatorial peptide library are aligned and immobilized by
application of a precision sieve. Subsequently, the chip is incubated with a fluorophore-labeled target
protein. In a fluorescence scan followed by matrix-assisted laser desorption/ionization (MALDI)-time
of flight (TOF) mass spectrometry, high-affinity binders are directly and unambiguously sequenced
with high accuracy without picking of the positive beads. The use of an optimized ladder sequencing
approach improved the accuracy of the de-novo sequencing step to nearly 100%. The new technique
was validated by employing a FLAG-based model system, identifying new peptide binders for the
monoclonal M2 anti-FLAG antibody, and was finally utilized to search for IgG-binding peptides.
In the present format, more than 30,000 beads can be screened on one slide.
Keywords: peptide library; screening; HTS; biomarker; on-bead sequencing; on-chip sequencing;
microarray; grid; bead array; drug screening; lead compounds; pharmaceutical development;
affinity reagents
1. Introduction
Peptides represent a class of pharmaceutical compounds, molecularly poised between small
molecules and proteins, yet biochemically and therapeutically distinct from both [1]. Among various
chemical library formats, one-bead-one-compound (OBOC) libraries are a proven approach for the
identification of protein-binding ligands [2]. By applying the split-and-mix method, introduced by
Lam et al., millions of compounds can be readily synthesized in parallel [3]. When these libraries are
created on resins that have a hydrophilic surface to suppress nonspecific reagent binding, they can be
used directly in binding screenings for the identification of ligands for proteins or other targets [4].
However, its potential has not yet been fully explored because of several technical obstacles,
including the screening of millions of beads by examination under a fluorescence microscope and
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manually isolating the positive beads by hand picking. Finally, the peptide will be released from the
bead and, subsequently, its sequence is determined, either directly by mass spectroscopic or indirectly
by encoded beads.
1.1. High-Throughput Screening Techniques for OBOC Libraries
To avoid these complex and laborious steps, several improvements of the OBOC technology have
been presented. A strategy for analyzing large libraries is bulk separation by protein-coated magnetic
particles [5]. Alternatively, the separation can be done by sorting beads using a system designated as
complex object parametric analyzer and sorter (COPAS), a modified flow cytometer (FACS), which is
compatible with beads typically used in OBOC libraries with a diameter in the range of 70–90 µm [6].
Conventional FACS systems may also be used for the same purpose, keeping in mind that these devices
are designed for analyzing cells in the size up to 10 µm [7]. For the automated isolation of positive
hits from large OBOC libraries, Hintersteiner et al. published a sophisticated confocal nanoscanning
and bead picking method (CONA), followed by sequencing of the binding peptides separately on
a µHPLC/mass spectrometry (MS) instrument [8]. Wang et al. developed chip-based techniques to
combine affinity experiments and the MS decoding of the peptide sequence. In a lithographic process,
a microstructured microwell array was manufactured, entrapping a single bead in each silicon well.
A capacity of 800 beads per chip was accomplished. On this silicon plate, fluorescence screening and
sequencing by matrix-assisted laser desorption/ionization (MALDI)-MS/MS were combined [9].
Other approaches to screen combinatorial libraries comprise the use of phage display [10] and
similar biological methods. Their library size can be very large. However, phage display libraries are
largely limited to proteinogenic amino acids and show some other unpleasant properties, such as severe
biases by parasitic sequences and other diversity deficiencies [11]. Recently, DNA-encoded libraries
seem to have gained some popularity, particularly in industry. First proposed by Brenner & Lerner in
1992, the emergence of next-generation sequencing technology may have fostered their renaissance [12].
Their main application seems to be in the screening of small molecule libraries. The application to
peptide libraries shows some disadvantages, such as “poor step economy relative to information
yield” [13]. Therefore, we believe that the OBOC approach still shows great promise [14] for the
screening of peptide libraries because of its extreme chemical flexibility; experimental simplicity; and by
the application of advanced analytical techniques, which gained significantly improved performance
during the last decades [15].
1.2. De Novo Peptide Sequencing from a Single Bead
The screening of OBOC libraries usually results in some positive beads, carrying multiple copies
of the respective target-binding peptide. Each of these beads needs individual and accurate sequence
determination. In the case of peptide libraries with a free N-terminus, Edman microsequencing can
be used [3,16]. However, this approach is expensive and time-consuming, which greatly restricts its
widespread application in high-throughput sequencing of OBOC libraries.
Today, mass spectrometry is the method of choice when it comes to the sequencing of multiple
peptides in a short time. Particularly, tandem mass spectrometry (MS/MS) is well established in
proteomics. MS/MS spectra, usually of chromatographically separated peptides produced by tryptic
digestion of a protein, are translated into peptide sequences, normally supported by various databases
including genetic information [17]. De novo sequencing of peptides by MS/MS from a single bead,
on the other hand, is an even more challenging task. In the case of the sequencing of peptides from
synthetic combinatorial libraries, database comparisons are not possible and the sequence identification
completely relies on the quality of the fragmentation spectra [18]. In practice, the fragmentation
processes in mass spectrometers are far from ideal and missing fragmentations can occur, making a
sequence determination difficult and error-prone. Karas et al. noted in a paper that despite several
advances in MS/MS in the past, a 100% sequence coverage may be “a modern form of surrealism” [19].
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Furthermore, comparative studies of the accuracy of several de novo algorithms showed that usually
only two-thirds of the residues in a peptide could be identified correctly [20,21].
Youngquist et al. introduced another encoding method, the so-called ladder synthesis approach
for peptide library creation [22], which was later modified by St. Hilaire et al. [23]. Here, a small amount
of a terminating reagent is added to each amino acid coupling step, generating the full-length products
plus a small percentage of sequence-truncated products. For example, Fmoc- and Boc-protected amino
acids, allowing deprotection of only the Fmoc-protected amines for continued synthesis and leaving
truncated fragments after cleavage from the solid support [23]. Direct measurement of the peptide
sequence is possible using matrix-assisted laser desorption/ionization (MALDI)-time of flight (TOF) MS
in one step without any fragmentation. In comparison to the MS/MS approach, an easy, straightforward,
and highly sensitive sequence read-out is possible, because of the deliberately generated ladder-like
peaks in the spectra.
1.3. Linker For Liquid Free Peptide Cleavage
The linker between polymer resin and peptide for a high-throughput analysis of peptide libraries
should allow the liquid-free cleavage from the resin leaving the peptides on or in the respective
bead. This is possible by using a photolabile linker [24], which is cleavable by UV-light prior to the
sequencing by MALDI-TOF MS/MS [25]. It was shown that a direct on-bead-sequencing of peptides
by MALDI-TOF MS/MS is possible [26]. Another approach is the release of resin-bound peptides by
ammonia vapors using the 4-hydroxymethylbenzoic acid (HMBA)-linker [27]. So far, this linker has
not been used for direct “on bead” sequencing but showed great promise in cleavage efficacy [28].
Here, we present a novel technique to identify protein binders from an OBOC library by
immobilizing the beads on a modified glass slide, on which the beads have been aligned by a
precision sieve. This also allows for a multiple step screening, in which the immobilized bead
library is sequentially incubated with fluorophore-labeled reagents, identifying suitable peptides by a
high-resolution fluorescence scan. In addition, a control screening (pre-screening) can be performed
to weed out false-positives caused by beads with high autofluorescence or non-specific protein
binding. To circumvent the need for a fragmentation step by MALDI-TOF MS/MS, which can result in
incomplete sequence information, a simple encoding approach (ladder sequencing) has been adapted
for this purpose. This allows for the peptide sequence identification by fragmentation-free MS with
almost 100% accuracy.
2. Materials and Methods
2.1. Chip Preparation
The chip was prepared by attaching an electrically conductive double-sided adhesive tape to a
glass microscope slide (75 × 25 mm2) and placing it in a custom-made holder. A metal sieve with a
mesh of 100 µm is pressed on the surface of the chip and dried beads are spread on the sieve, which
stick to the adhesive tape below. Finally, the sieve and any loosely bound beads are removed, resulting
in a regular, grid- or array-like layer of beads, which is favorable for an overlapping-free MALDI-TOF
MS sequencing process.
2.2. On-Chip Protein Incubation
All incubation steps were performed directly on the chip surface in PBS-T BSA (pH 7.5; 0.1%
Tween 20; 1% BSA) in a petri dish. Prior to the first incubation, the chip-bound beads were pre-swollen
by covering the chip with PBS-T BSA and gentle shaking for one hour. The chip was washed five times
with PBS-T BSA and incubated with the primary antibody (1 mg/mL; 1:10,000 diluted in PBS-T BSA)
overnight, washed, and incubated with the same concentration of anti-mouse IgG-Atto633 antibody
for one hour. The chip was washed and dried before performing high-resolution fluorescence imaging
using a microarray scanner MArS (Ditabis AG) using a laser wavelength of 635 nm. For further
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experiments, all proteins were removed by treating the chip with 6 M guanidinium chloride solution
and subsequent washing steps with high-purity lab water.
2.3. On-Bead Peptide Ladder Sequencing by MALDI-TOF MS
The dried chip was placed in a chamber with concentrated ammonia solution at the bottom for
two hours. The matrix application was achieved using a conventional airbrush gun. About 2 mL of
the matrix solution was used per chip, consisting of 20 mg of 2,5-dihydroxyacetophenone in ethanol
and diammonium hydrogen citrate (18 mg/mL in MilliQ lab water) (3:1 v/v). The matrix solution was
applied from a distance of 13 cm and with a pressure of 2 bar. MALDI-TOF MS and MALDI-TOF MS/MS
sequencing were performed using a Bruker autoflex II smartbeam™ mass spectrometer. Coordinates
of positive peptides, obtained from the microarray scans, were transformed by linear regression and
via calibration of four beads on the corners of the slide. Peptide mass spectra were directly acquired on
the bead surface.
2.4. Resin preparation
TentaGel HL NH2 beads (75 µm, 0.47 mmol/g) were swollen in dimethylformamide (DMF) for
1 h before usage. The linker was coupled on the resin by adding 4-(hydroxymethyl)benzoic acid
(HMBA) (0.1 mol/L, 4 eq.) in DMF with O-(1H-6-chlorobenzotriazole-1-yl)-1,1,3,3-tetramethyluronium
hexafluorophosphate (HCTU) (4 eq.), and N-methylmorpholine (NMM) (8 eq.) for 1 h. Glycine
was incorporated at the C-terminus by adding Fmoc-Gly-OH (0.3 mol/L, 5 eq.) in dichloromethane
(DCM) with diisopropyl carbodiimide (DIC) (2.5 eq.), followed by dropwise addition of a solution
of dimethylaminopyridine (DMAP) dissolved in DMF (50 mmol/L, 0.1 eq.). The spacer sequence
GGTERSG was synthesized by adding Fmoc-amino acids (0.1 mol/L, 4 eq.) in DMF to the beads using
HCTU (4 eq.), and NMM (8 eq.) for 1 h. The Fmoc protection group was cleaved off by 20% piperidine
in DMF for 30 min. Beads were washed thoroughly with DMF after each step.
2.5. Peptide Ladder Synthesis
For the synthesis of the peptides, Fmoc-amino acids (0.1 mol/L, 4 eq.) and Boc-amino acids (0.2 eq.)
in DMF were coupled to the prepared resin using HCTU (4 eq.), and NMM (8 eq.) for 1 h. Fmoc was
cleaved off by 20% piperidine in DMF for 30 min. The monitoring of the dibenzofulvene-piperidine
adducts during the peptide synthesis revealed that between 3% and 10% Boc-protected amino acids
were incorporated during every coupling step. On average, 60%–80% of the peptides on the surface
are full-length peptides (Supplement, Figure S7). Beads were washed thoroughly with DMF after each
step. The side chains and Boc-truncated peptides were deprotected by treatment with trifluoroacetic
acid (TFA)/triisopropylsilane (TIS)/H2O (95/2.5/2.5 v/v/v) twice for 2 h, respectively.
2.6. Synthesis of the Split-and-Mix One-Bead-One-Compound Peptide Library
The fully randomized peptide library was synthesized on the prepared resin by following ladder
synthesis protocol by manually splitting the resin in aliquots. Subsequently, all resin aliquots were
mixed for washing, acetylation, and Fmoc deprotection. The cycle of splitting and mixing was repeated
until the desired peptide length was accomplished. Finally, the resin was treated with a mixture of
95% trifluoroacetic acid (TFA), 2.5% triisopropylsilane (TIS), and 2.5% deionized water to remove side
chain protecting groups, followed by intensive washing with DCM and drying of the resin in vacuo.
2.7. Surface Plasmon Resonance (SPR) Experiments
Surface plasmon resonance (SPR) experiments were performed on a Reichert SR7500DC dual
channel SPR system. A total of 100 µL of 100 µg/mL of the antibody in 1 mM sodium acetate (pH 5.0)
was immobilized onto one flow channel of the biosensor chip HC200 (XanTec bioanalytics, Düsseldorf,
Germany) using a standard amine coupling protocol (Supplement, SPR chip preparation) [29]. Peptide
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stock solutions (1 and 10 mM) were prepared in HBS-EP (pH 7.4, 0.01 M 4-(2-hydroxyethyl)-1-piperazine
ethanesulfonic acid (HEPES), 0.15 M NaCl, 3 mM EDTA, 0.005% Tween 20) and later diluted in HBS-EP
buffer. Peptide binding was performed in a multiple kinetics mode using HBS-EP as a running buffer.
Binding kinetics parameters were calculated using TraceDrawer Data Analysis Software.
More details of most experiments can be found in the Supplementary Materials.
3. Results
3.1. High-Throughput Screening
A peptide library with a length of eight amino acids was synthesized on a TentaGel HL NH2
(75 µm) resin, which is suitable for both peptide synthesis in organic media and biochemical assays
in aqueous buffers. The peptides were attached to the resin via a base-labile HMBA-linker, which is
compatible with Fmoc chemistry and does not interfere with the MS analysis after cleavage.
To achieve a high-throughput method, a screening process based on a fluorescence read-out with
a microarray scanner and peptide identification via MALDI-TOF MS was performed on the same
chip. These glass-based chips were prepared by modifying the surface of a microscope slide with
an electrically conductive, double-sided adhesive tape. A metal sieve with a mesh of 100 µm was
pushed on the surface of the adhesive tape. The dried beads were poured on the sieve and manually
spread to allow the beads to fill the meshes. Slight pressing on top of the resin beads ensured their firm
attachment on the sticky surface. The removal of the grid resulted in an ordered layer of beads on the
chip surface, where every bead has a defined distance to the adjacent beads (Supplement, Figure S1).
Between 30,000 and 50,000 beads can be immobilized on one chip using this procedure.
All reaction steps were performed directly on the chip by incubating with the labeled target
molecules. The beads, displaying target-binding peptides, were identified by a high-resolution
fluorescence scan using a suitable wavelength corresponding to the fluorescence label of the target
(Figure 1).
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Figure 1. Illustration f the on-chip screening for e ti e- ased protein binders. The chi is prepared
by sieving the one-bead-one-compound (OBOC)-library (i) on a glass slide covered with an electrically
conductive, double-sided adhesive tape (ii). On-chip incubation with the target protein and a
labeled secondary antibody is performed (iii), followed by a high-resolution fluorescence scan for the
identification of protein binding peptides. For peptide cleavage, the chip is placed in a chamber with
ammonia vapor (iv). using matrix-assisted laser desorption/ionization (MALDI) matrix is applied with
an airbrush (v) and the sequence read-out of positive peptides is achieved via ladder sequencing by
MALDI-time of flight (TOF) mass spectrometry (MS).
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For sequence determination on the same chip, the peptides were released by placing the slide in
a chamber with gaseous ammonia for a minimum of two hours. Matrix application was performed
using a conventional airbrush gun. Under a light microscope, a thin layer of the matrix is visible on the
surface of the beads (Supplement, Figure S2). No cross contamination of the peptides was observed.
3.2. Ladder Sequencing
De novo sequencing in general, as already described, is a challenging task. A ladder sequencing
approach was established based on the technique of St. Hilaire et al. [23]. In contrast to the previously
described methods, not 10%, but only 5% of the Boc-protected amino acids were added as truncation
agents in each coupling step (Figure 2), ensuring that the majority of peptides on the surface contain
the full-length sequence.
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protection groups are removed by 95% trifluoroacetic acid (TFA).
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The beads containing positive peptides were identified by fluorescence imaging and their
coordinates were transformed into coordinates for the MALDI mass spectrometer. After peptide
cleavage by ammonia vapor and subsequent matrix application, the peptides were sequenced by
MALDI-TOF MS directly on the bead surface without any manual manipulation. The ladder-like
peaks allowed an easy structural sequence assignment. As this sequencing method mainly relies
on the mass difference between the peaks, corresponding to the molecular weight of the respective
amino acid building block, this method is less dependent on precise external calibration, which may be
time-consuming and inconvenient.
Though the method leads to truncated peptide species on the beads, it can be expected that the
shorter peptides do not interfere with the screening process in most cases. On the one hand, they are
present in a relatively low concentration and on the other hand, shorter peptides can be assumed and
are reported to show lower affinities than their full-length counterparts [30].
To establish an unbiased and high-throughput method for the evaluation of peptide truncation
spectra, an algorithm was developed allowing for their automated processing [31]. This provides a
convenient tool for the decoding of the sequences from the MALDI-TOF MS. In the software tool,
the most abundant peak is defined as the full-length peptide. The peaks at lower m/z are assigned
automatically and compared to the theoretical ladder sequences of all peptides from the underlying
peptide library. The peptide sequences are sorted by the number of matching amino acids. For parallel
analysis, a batch process is included, allowing for the high-throughput processing of multiple spectra.
3.3. Prescreening
The screening of an OBOC library often requires a secondary protein that is labeled with a
fluorophore or enzyme. For example, secondary antibodies [5] or streptavidin for staining biotinylated
proteins have been used [32]. In these cases, false positive peptides might be identified that show
affinity to the secondary reagent and not to the target protein. Furthermore, it is known that occasionally
some defective TentaGel beads show a high autofluorescence [33]. These false positive hits are a major
technical issue in OBOC libraries. Ding et al. suggested identifying these beads prior to the screening
to remove these beads manually [34]. In our chip-based technique, manual elimination is not necessary.
The bead-coated chip can be examined by a high-resolution fluorescence scan in advance. Thus, any
beads showing a high autofluorescence can be identified and flagged. Furthermore, the chip can be
incubated solely with the secondary fluorophore-labeled antibody without the target to identify any
false positives binding to the secondary reagent. Regeneration of the chip by denaturing reagents such
as urea or guanidine hydrochloride can be used to remove bound reagents. The fluorescence intensities
from the target screening and the prescreenings were compared. Only if the detected intensity of a
single bead in the target screening was three times higher than in the prescreening, the bead was
considered as a “hit” (Figure 3).
3.4. Screening Validation
To examine and validate the technical aspects of the presented screening technique, the well-established
FLAG peptide [35] in combination with the monoclonal mouse anti-FLAG antibody M2 was chosen [36].
Four peptides were separately synthesized on TentaGel beads, from which one peptide contained the
known FLAG sequence and three others contained the random peptides. The four model peptides
were synthesized using the described ladder synthesis, theoretically resulting in 66% of the full-length
peptide and 34% of truncation sequences. Fifty FLAG peptide-displaying beads were doped into about
50,000 beads displaying random peptides, which had been tested to show no significant interaction
with the M2 anti-FLAG antibody. Experiments were performed to test the efficiency with which the
known number of FLAG peptide-displaying beads could be identified from a mock library. A total of
33,000 of the 50,000 beads could be immobilized on a single slide. The slide with the immobilized beads
was incubated with the anti-FLAG antibody, followed by washing and staining with the fluorescent
anti-mouse antibody (Atto633 conjugate). A total of 35 out of about 33,000 beads could be identified as
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binders by a high-resolution fluorescence scan (Figure 4). The sequence identification was performed
directly on the same chip as described above. The peptides were cleaved from the beads, the matrix
was applied on the chip, and the coordinates of the FLAG antibody binding beads were transformed
for MALDI-TOF MS and directly measured on the bead surface. The ladder-like sequence peaks were
obtained, allowing a structural assignment, and all 35 peptides were identified as FLAG peptides.High-Throughput 2019, 8, x FOR PEER REVIEW 8 of 15 
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on-chip screening. Overlay of green (excitation 532 nm, emission 570 nm) and red (excitation 635 ,
e issi 670 nm) fluorescence. Green fluorescence was used to detect all TentaGel beads utilizing their
auto-fl orescence a d red fluorescence was used to i entify positive beads. Left: prescreening with
the secondary labeled antibody (re fluorescenc dye) for false positive identification. Right: target
sc e ning with the target protein followed by s condary a tibody. The beads with the numb rs 1 and 2
show a significantly h gher fluorescence intensity and were hence considered a “hits”. In contrast,
the beads with the numbers 3, 4, and 5 show similar intensities in the prescreening and target screening
and were flagged as f lse positive .
3.5. Validation of the Ladder Sequencing
The robustness of the ladder sequencing was first tested by the automatic sequence determination
of the four model peptides. Therefore, three FLAG peptides and three of each of the non-FLAG
peptides were directly examined on the bead surface. They were easily identified by the parent mass
and the calculated sequence compared with the expected sequence. Overall, 100% of the amino acids
were identified at the correct position in the sequence (Supplement, Tables S5–S8).
To compare the sequencing by MS/MS fragmentation from a single bead with the ladder sequencing,
the most abundant peaks from the measured peptides were fragmented. The parent ion mass was
detected in high intensities, the detection of some fragment ions, on the contrary, was difficult, if not
impossible. As shown in Figure 5, the intensity of the fragment ions is low in comparison with that of
the parent ion, and several cleavage sites are missing completely. This lack of information leads to
an incomplete sequence assignment. One reason for the poor fragmentation efficiency, in addition
to the aforementioned problems, is the very small sample amount of a single bead. A custom-made
search tool was used, automatically identifying the corresponding peptide sequences. The results are
summarized in Table 1, showing that only 29% of the amino acids within an individual sequence were
recognized correctly by MS/MS (Supplement, Tables S1–S4).
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1700.75 DYKDDDDK 46 17 100 100
1600.76 DTHFPIGG 63 20 100 100
1586.73 VPFHTDGG 50 33 100 100
1737.94 KFVPFKKS 62 16 100 100
3.6. Targeted Screening for Anti-FLAG Antibody Ligands
To explore the potential of the developed method, a targeted peptide library was synthesized for
the identification of peptides binding to the FLAG antibody M2. This clone binds to a well-studied
epitope, consisting of the amino acids DYKXXD [37].
For the library synthesis, the five L-amino acids threonine, isoleucine, aspartic acid, lysine,
and tyrosine were used. The library was synthesized using conventional split-and-mix synthesis.
The cycle of splitting and mixing was repeated eight times, resulting in a theoretical diversity of
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390,625 peptides. A chip was prepared with about 12,000 immobilized beads in total. Prescreening
was performed, in which approximately 10% of the positive beads were identified as false positives.
It can be assumed that in a larger and more complex library, the fraction of false positive beads may be
even higher (Scans in Supplement, Figure S3).
The chip was then incubated with the primary anti-FLAG antibody for 15 h, followed by incubation
with the secondary antibody for 1 h. The chip was analyzed by high-resolution fluorescence scan.
Thirty-three beads with the highest fluorescence were identified as anti-FLAG antibody binding
peptides and selected for ladder sequencing. All sequences are listed in the Supplement. Most selected
sequences showed either the epitope DYKXXD (10) or partial epitopes with three out of the four
amino acids of the epitope (14). Eight of the sequences contain less or no obvious parts of the epitope
(all sequences in Supplement, Table S9).
For characterization, three of the positive peptides were resynthesized—Peptide 1 (DYKDYDKD)
containing the known epitope and Peptide 2 (DYIDYDYK) representing a partial epitope. Peptide 3
(DYDIYIYD) was created as a consensus peptide by choosing the most abundant amino acid at every
position from 32 identified positive peptides.
Surface plasmon resonance (SPR) and on-bead fluorescence assays were performed to estimate
the binding affinities of the given peptides. In the fluorescence assays, the beads with the respective
peptides were incubated with the anti-FLAG antibody and stained with the fluorescent secondary
antibody. For the SPR experiments, the anti-FLAG antibody M2 was immobilized on an HC200
chip and peptide solutions from 6 nM to 1 µM were examined. The results are presented in Table 2
(Supplement, Figure S5).
Table 2. Sequences of the FLAG peptide and three resynthesized positive peptides. The relative
fluorescence determined by on-bead incubation with the anti-FLAG antibody, setting the fluorescence
intensity of the FLAG peptide to 100%. Equilibrium dissociation constant (KD) measured by surface
plasmon resonance (SPR).
Peptide Sequence Relative Fluorescence KD, nM
FLAG DYKDDDDK 100% 50 ± 30/31 [38]
Peptide 1 DYKDYDKD 97% 15 ± 5
Peptide 2 DYIDYDYK 37% 240 ± 60
Peptide 3 DYDIYIYD 73% 12 ± 5
3.7. Non-Targeted Screening for IgG Ligands
Peptides binding specifically to IgG are of special interest in the emerging market of monoclonal
antibodies for diagnostic and particularly therapeutic purposes [39]. The isolation of antibodies from
complex sera or cell culture media is usually performed by affinity columns with immobilized protein
A. The advantage of using peptides in contrast to proteins is that they can be produced synthetically
and do not contain any impurities from a microbiological origin. Additionally, they are much smaller
than proteins, allowing a higher ligand density on the affinity column.
For the library synthesis, the eight amino acids, serine, isoleucine, glycine, glutamic acid,
arginine, phenylalanine, proline, and histidine, were used. The total length of seven amino acids per
peptide results in a theoretical library size of 2,097,152 different peptides. A chip was prepared by
immobilization of about 33,000 beads. The screening was performed using polyclonal mouse IgG
and an anti-mouse IgG Atto633 for staining (Scans in Supplement, Figure S4). Nine peptides were
identified as antibody binding and their sequence was successfully determined by ladder sequencing
(Supplement, Table S10). Three of the identified peptides were synthesized and their affinities were
analyzed by SPR. The measured affinities are in the micromolar range (Table 3; Supplement, Figure S6).
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Table 3. Equilibrium dissociation constants (KD) for peptide mouse IgG interaction determined by SPR.
Peptide Sequence KD, µM
IgG BP 1 GRIHGPR 14 ± 1
IgG BP 2 GIHPFGR 50 ± 10
IgG BP 3 GEPFSIP 20 ± 30




The presented on-chip screening technique was developed by modifying a glass-based microscopy
slide with double-sided conductive tape. The beads are immobilized spreading them through a sieve,
which is an easy and cost-effective alternative to complex fabrication processes used previously for
other chips [9]. The screening was successfully validated by utilizing a FLAG-based model system.
It was shown that screening and sequence identification is possible on the same chip. This allows for
the rapid and reliable identification of peptides as protein binders without any manual bead picking
or manipulation.
Thirty-five out of 50 positive peptide beads could be recovered from a mock library of 50,000
beads in total. During the whole process, no cross contamination by peptides from neighboring beads
was observed.
The loss of 15 positive beads can be rationalized by the limitations of the immobilization procedure.
Because of the soft polyethylene glycol surface of TentaGel beads, about one-third of the beads stuck
on the utilized sieve and were not immobilized on the modified chip. In the screening of real libraries,
the losses are not very relevant, because primarily, the overall number of beads screened is important
in OBOC libraries.
The occurrence of false positive hits is by far the severest limitation of combinatorial libraries.
The novel and robust chip format allows for repeated regeneration of the chip surface by denaturation
of bound proteins. This opens the possibility for multi-step incubations and control scans, highly
reducing the number of false positive hits. This is an additional improvement to the chip-based
technologies presented previously [9].
For the challenging de novo sequencing by MALDI-TOF MS, a powerful encoding strategy using
a peptide ladder synthesis was established. The results presented in Table 1 clearly show that the
ladder sequencing technique results in significantly better sequence reliability in comparison with the
classical fragmentation technique.
The technique was tested by screening a targeted library against anti-FLAG antibody M2 and
33 peptides were identified as positive. One-third of the peptides contain the known epitope for the
anti-FLAG antibody. The rest of the identified sequences display parts of the epitope or no previously
reported epitopes. These are designated as mimotopes—peptides which mimic the structure of an
epitope [41]. Three of these newly identified peptides were characterized with on-bead incubation by
fluorescence assay and SPR (Table 2). The relative fluorescence intensities measured on the beads are
in acceptable agreement with the values determined with SPR. Peptide 1, which contains five amino
acids identical to the known FLAG sequence, shows affinities comparable to the literature value of
31 nM [38]. The mimotope Peptide 2 shows significantly lower affinities. Interestingly, the consensus
Peptide 3 shows one of the highest affinities of the respective peptides, without containing any reported
epitope for the anti-FLAG antibody M2. This demonstrates that this screening technique unbiasedly
identifies protein binders, revealing new peptide binders for the anti-FLAG antibody M2.
In a non-targeted approach, a library was screened against mouse immunoglobulins, resulting in
several peptides with a significant binding property. Four of these peptides were resynthesized and
characterized by SPR, showing micromolar affinities (Table 3). For linear peptides of this size, affinities
in this range are in good agreement with the literature [42].
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5. Conclusions
An on-chip technique was developed, which is comprised of an OBOC peptide library immobilized
on a surface, followed by protein-binding assays based on high-resolution fluorescence detection and
direct on-bead peptide sequencing by mass spectrometry. The “all-on-one chip” system eliminates
tedious separation or manual picking steps and may greatly facilitate the discovery of protein binders
from peptide libraries. Furthermore, the novel chip format allows multi-step incubations, which opens
the possibility for control scans, highly reducing the number of false positive hits. Finally, the technique
was tested successfully by screening a targeted and a non-targeted peptide-library, revealing new
peptide binders for the anti-FLAG antibody M2 and mouse immunoglobulins.
The presented chip-based technique can be adapted further for multiple application of OBOC
libraries. Using a comparable strategy peptide-PEG conjugates for the solubilization of the drug BB17
could be identified [26].
By combining this approach with a prior magnetic enrichment strategy as described by
Mendes et al. [5], the library size might be increased even further. Additionally, if the diameter
of the beads could be reduced, a significantly higher number of immobilized beads per chip could
be achieved.
Supplementary Materials: The following are available online at http://www.mdpi.com/2571-5135/8/2/11/s1.
1. Materials, 2. Resin preparation, 3. Peptide synthesis, 4. Synthesis of peptide library 1, 5. Synthesis of peptide
library 2, 6. Chip preparation, 7. Cleavage of peptides and matrix-application via airbrush gun, 8. Sequencing of
test peptides by MALDI-TOF MS/MS (fragmentation), 9. Ladder-sequencing of test peptides by MALDI-TOF
MS, 10. Incubation with anti-FLAG antibody M2, 11. Ladder sequencing of the peptides selected from library
1 after anti-FLAG antibody incubation, 12. Ladder sequencing of the peptides selected from library 2 after
polyclonal mouse IgG incubation, 13. Peptide ladder-sequencing by MALDI TOF MS/MS of library 2, 14. SPR
chip preparation, 15. SPR characterization of anti-FLAG binding peptides, 16. SPR characterization of mouse IgG
binding peptides.
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